A1 Vertaisarvioitu alkuperäisartikkeli tieteellisessä lehdessä

Tissue slice grafts of human renal cell carcinoma: An authentic preclinical model with high engraftment rate and metastatic potential – An authentic preclinical model with high engraftment rate and metastatic potential




AlaotsikkoAn authentic preclinical model with high engraftment rate and metastatic potential

TekijätAlan E. Thong, Hongjuan Zhao, Alexandre Ingels, Maija P. Valta, Rosalie Nolley, Jennifer Santos, Sarah R. Young, Donna M. Peehl

Julkaisuvuosi2014

JournalUrologic Oncology: Seminars and Original Investigations

Vuosikerta32

Numero1

Aloitussivu43.e23

Lopetussivu43.e30

Sivujen määrä8

ISSN1078-1439

eISSN1873-2496

DOIhttps://doi.org/10.1016/j.urolonc.2013.05.008


Tiivistelmä

Objective: Discovery ofcurativetherapiesforrenalcellcarcinoma(RCC)ishamperedbylackofauthenticpreclinicalmodels.

Tumorgrafts, generatedbydirectimplantationofpatient-derivedtissuesintomice,havedemonstratedsuperiorabilitytopredicttherapeutic

response. Weevaluated “tissue slicegrafts” (TSGs) asanimprovedtumorgraftmodelofRCC.

Materials andmethods: Cores offreshRCCwereprecision-cutat300 mm andimplantedundertherenalcapsuleofRAG2−/−γC−/−

mice. Engraftmentrate,histology,biomarkerexpression,genetic fidelity, andmetastaticpotentialwereevaluated.Magneticresonance

imaging (MRI)wastestedasanoninvasivemethodtomeasuretumorvolume,andresponsetoatargetedtherapywasdetermined.

Results: All 13casesofRCCengraftedanddisplayedcharacteristichistologyandbiomarkers.TSGvolumequantified noninvasivelyby

MRI highlycorrelatedwithgraftweights,providingauniquetoolformonitoringorthotopicgrowth.Moreover,in2cases,cancercellsfrom

TSGs metastasizedtoclinicallyrelevantsites,includingbone.MicroarrayanalysisandDNAsequencingdemonstratedahighdegreeof

correlation ofglobalgeneexpressionandvonHippel-Lindau(VHL)statusbetweenTSGsandparentaltumors.TreatmentofTSGswith

sunitinib significantly decreasedgraftweightandmeanvesseldensitycomparedwithcontrols.

Conclusion: The TSGmodelofRCCfaithfullyrecapitulatestumorpathology,geneexpression,geneticmutation,anddrugresponse.The

high engraftmentrateandmetastaticpotentialofthisauthenticmodel,inconjunctionwiththeabilitytogeneratelarge first-generation animal cohorts andtoquantitatetumorvolumeattheorthotopicsitebyMRI,proffersignificant advantagescomparedwithotherpreclinical platforms.




Last updated on 2024-26-11 at 18:52